Followers | 28 |
Posts | 5937 |
Boards Moderated | 1 |
Alias Born | 04/28/2013 |
Tuesday, September 24, 2024 8:26:58 PM
Recent NVAX News
- Form 8-K - Current report • Edgar (US Regulatory) • 01/13/2025 12:50:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2025 10:41:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2025 09:52:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2025 09:47:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2025 09:44:15 PM
- Form 144/A - Report of proposed sale of securities: [Amend] • Edgar (US Regulatory) • 01/02/2025 09:02:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/30/2024 10:27:14 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/26/2024 03:31:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/18/2024 10:24:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/13/2024 10:24:48 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/13/2024 05:13:06 PM
- Novavax Advances Corporate Growth Strategy Through Sanofi Partnership, Including Achievement of First $50 Million Milestone • PR Newswire (US) • 12/13/2024 01:00:00 PM
- Novavax Initiates Phase 3 Trial for COVID-19-Influenza Combination and Stand-Alone Influenza • PR Newswire (US) • 12/10/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/04/2024 11:00:38 AM
- Novavax Announces Sale of Czech Republic Manufacturing Site to Novo Nordisk for $200 Million • PR Newswire (US) • 12/04/2024 07:00:00 AM
- Novavax Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635(c)(4) • PR Newswire (US) • 11/15/2024 12:47:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/13/2024 09:08:57 PM
- Novavax to Participate in Jefferies London Healthcare Conference • PR Newswire (US) • 11/13/2024 01:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2024 09:08:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2024 04:21:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2024 01:04:48 PM
- Novavax Reports Third Quarter 2024 Financial Results and Operational Highlights • PR Newswire (US) • 11/12/2024 01:02:00 PM
- U.S. FDA Removes Clinical Hold on Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Phase 3 Trial • PR Newswire (US) • 11/11/2024 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/05/2024 10:01:06 PM
- Novavax to Host Conference Call to Discuss Third Quarter 2024 Financial Results and Operational Highlights on November 12, 2024 • PR Newswire (US) • 11/04/2024 09:30:00 PM
FEATURED Zefiro Methane Corp. Subsidiary Awarded Slate of Government of Ohio-Funded Environmental Remediation Projects • Jan 15, 2025 7:33 AM
FEATURED Mawson Finland Begins 2025 Drill Program, Mobilizing Multiple Drill Rigs at Rajapalot • Jan 15, 2025 7:18 AM
UAV Corp (OTC: UMAV) Engages Legal Counsel to Initiate Uplisting Process with Ultimate Goal of NASDAQ Listing • UMAV • Jan 15, 2025 8:30 AM
HealthLynked Welcomes Jeremy Daniel as Chief Financial Officer • HLYK • Jan 15, 2025 8:00 AM
GreetEat Corporation Announces Ticker Symbol Change to GEAT on OTC Markets • GEAT • Jan 14, 2025 9:40 AM
Unitronix Corp. Expands Stock Buyback Program, Reducing Outstanding Shares by Total of 165M • UTRX • Jan 14, 2025 8:14 AM